“…[3][4][5][6] Currently, only a few established commercial bactericides, namely, bismerthiazol (BT), etridiazole, benthiazole and thiodiazole copper (TC), are used for the treatment of these plant bacterial diseases. Unfortunately, longterm use of these antimicrobial agents has resulted in the emergence of antimicrobial resistance in many of these pathogenic bacteria, [7][8][9] so the discovery of new antibiotics that elicit their antimicrobial activity through novel modes of action is very important. 10,11 Recently, 1,4-benzoxazin-3-one derivatives have gained increasing attention because of their broad pharmacological activities, including examples that display antibacterial, 12,13 antifungal, 14,15 herbicidal, 16,17 anticancer, 18,19 neurodegenerative diseases 20 and platelet aggregation inhibitor activities.…”